Yu. V. Shubik

958 total citations
30 papers, 198 citations indexed

About

Yu. V. Shubik is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Yu. V. Shubik has authored 30 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Yu. V. Shubik's work include Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (22 papers) and Cardiac electrophysiology and arrhythmias (21 papers). Yu. V. Shubik is often cited by papers focused on Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (22 papers) and Cardiac electrophysiology and arrhythmias (21 papers). Yu. V. Shubik collaborates with scholars based in Russia, Sweden and United States. Yu. V. Shubik's co-authors include Arne Lindgren, Pyotr G. Platonov, Jonas Carlson, Golitsyn Sp, N. Yu. Mironov, S. Bertil Olsson, E. I. Chazov, Varvara A. Ryabkova, Yehuda Shoenfeld and Darja Kanduc and has published in prestigious journals such as SHILAP Revista de lepidopterología, Autoimmunity Reviews and International Journal of Cardiology.

In The Last Decade

Yu. V. Shubik

27 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu. V. Shubik Russia 9 171 24 22 12 11 30 198
Nikolaos Karamichalakis Greece 8 276 1.6× 17 0.7× 17 0.8× 18 1.5× 24 297
Raju George India 7 71 0.4× 16 0.7× 33 1.5× 13 1.1× 15 1.4× 19 123
Grazia Valsecchi Italy 4 164 1.0× 20 0.8× 38 1.7× 15 1.3× 5 0.5× 5 220
Kazuo Miyazawa Japan 10 276 1.6× 18 0.8× 23 1.0× 11 0.9× 1 0.1× 36 303
Gregory Jackson United States 5 62 0.4× 25 1.0× 8 0.4× 12 1.0× 9 103
Е. Д. Космачева Russia 5 54 0.3× 19 0.8× 21 1.0× 7 0.6× 70 97
W. Anné Belgium 5 245 1.4× 19 0.8× 10 0.5× 16 1.3× 7 261
Nabeel Ahmed United Kingdom 4 50 0.3× 24 1.0× 11 0.5× 12 1.0× 8 97
Jorge L. Riera Stival Argentina 3 125 0.7× 30 1.3× 4 0.2× 9 0.8× 5 134
Mark Sopher United Kingdom 6 226 1.3× 9 0.4× 6 0.3× 31 2.6× 13 257

Countries citing papers authored by Yu. V. Shubik

Since Specialization
Citations

This map shows the geographic impact of Yu. V. Shubik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu. V. Shubik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu. V. Shubik more than expected).

Fields of papers citing papers by Yu. V. Shubik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu. V. Shubik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu. V. Shubik. The network helps show where Yu. V. Shubik may publish in the future.

Co-authorship network of co-authors of Yu. V. Shubik

This figure shows the co-authorship network connecting the top 25 collaborators of Yu. V. Shubik. A scholar is included among the top collaborators of Yu. V. Shubik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu. V. Shubik. Yu. V. Shubik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shubik, Yu. V., A. Korneev, & Alexandre V. Morozov. (2025). Hemodynamic significance of ventricular ectopic beats: the impact of coupling intervals. 32(1). 64–70.
2.
Shubik, Yu. V., et al.. (2025). Antiarrhythmic drugs of class Ic in cardiology practice. Vrach. 32–38. 1 indexed citations
3.
Shubik, Yu. V., et al.. (2024). Elderly patient with syncope: the clinical case. 19(2). 108–117. 1 indexed citations
4.
Shubik, Yu. V., et al.. (2024). The results of I phase clinical study of class III antiarrhythmic drug, tablet form. Siberian Journal of Clinical and Experimental Medicine. 38(4). 141–150. 1 indexed citations
5.
6.
7.
8.
9.
Mironov, N. Yu., Yu. V. Shubik, Golitsyn Sp, et al.. (2021). Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety. SHILAP Revista de lepidopterología. 17(5). 668–673. 7 indexed citations
10.
Mironov, N. Yu., Yu. V. Shubik, Golitsyn Sp, et al.. (2021). Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness. SHILAP Revista de lepidopterología. 17(2). 193–199. 17 indexed citations
11.
Shubik, Yu. V., et al.. (2021). Management of atrial fibrillation in Russia: real clinical practice and current clinical guidelines. 28(2). 55–63. 4 indexed citations
12.
Ryabkova, Varvara A., Leonid P. Churilov, & Yu. V. Shubik. (2020). Role of autoantibodies against cardiomyocyte antigens in the development of cardiac arrhythmiae and sudden cardiac death. 26(4). 21–31. 1 indexed citations
13.
Shubik, Yu. V.. (2020). Bidirectional ventricular tachycardia: what is it?. 26(4). 59–63. 1 indexed citations
14.
Ryabkova, Varvara A., et al.. (2019). Lethal immunoglobulins: Autoantibodies and sudden cardiac death. Autoimmunity Reviews. 18(4). 415–425. 24 indexed citations
15.
Mironov, N. Yu., et al.. (2019). Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety. SHILAP Revista de lepidopterología. 14(6). 826–830. 10 indexed citations
16.
Mironov, N. Yu., et al.. (2018). Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness. Rational Pharmacotherapy in Cardiology. 14(5). 664–669. 18 indexed citations
17.
Cortez, Daniel, Arne Lindgren, Jonas Carlson, et al.. (2017). Atrial time and voltage dispersion are both needed to predict new-onset atrial fibrillation in ischemic stroke patients. BMC Cardiovascular Disorders. 17(1). 200–200. 13 indexed citations
18.
Lindgren, Arne, et al.. (2015). Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke. International Journal of Cardiology. 199. 248–252. 21 indexed citations
19.
Lindgren, Arne, et al.. (2014). Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?. EP Europace. 16(12). 1714–1719. 16 indexed citations
20.
Lindgren, Arne, et al.. (2013). Documentation of atrial fibrillation prior to first-ever ischemic stroke. Acta Neurologica Scandinavica. 129(6). 412–419. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolaos Karamichalakis Breakdown of academic impact, for papers by Raju George Breakdown of academic impact, for papers by Grazia Valsecchi Breakdown of academic impact, for papers by Kazuo Miyazawa Breakdown of academic impact, for papers by Gregory Jackson Breakdown of academic impact, for papers by Е. Д. Космачева Breakdown of academic impact, for papers by W. Anné Breakdown of academic impact, for papers by Nabeel Ahmed Breakdown of academic impact, for papers by Jorge L. Riera Stival Breakdown of academic impact, for papers by Mark Sopher
Rankless by CCL
2026